Registration Deadline:
Vanderbilt Contact:
Explore other Industry Opportunities:
GenScript's second-year initiative supporting breakthroughs in life science research by providing grant funding specifically earmarked for purchasing GenScript reagents and services, leveraging comprehensive "one-stop" solutions through advanced technologies and platforms.
Overview
- Funding up to $100,000 USD maximum per project with variable funding levels based on project budget needs
- Over 50 grants planned for award based on scientific merit, potential for impact, and strategic alignment
- Access to GenScript's comprehensive technologies and platforms for identified research areas
- Global partnership opportunities with GenScript investigators
- Funding specifically designated for GenScript reagents and services
Priority Areas
- Gene and Cell Therapy Development
- Antibody Drug Discovery
- AI Drug Discovery
- Vaccine Development
- Diagnostics
Eligibility & Requirements
- Researchers in diverse life science fields are encouraged to apply
- Projects must align strategically with GenScript's primary areas of scientific interest
- Evaluation based on scientific merit, potential for impact, and strategic alignment with
- GenScript interests: Projects expected to commence promptly after receiving grant funding
Timeline
- November 15, 2025: Application deadline (EST)
- November 16 - December 19, 2025: Application review period
- December 20, 2025: Award announcement
- Research activities should generally take place over 12 months or less
Please note: Full RFP is attached in the "More Information" section of this page. Faculty and researchers interested in applying for these opportunities based on technologies developed or disclosed at Vanderbilt must submit their proposals through the CTTC.